Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associations

Translational Research

Volumn 150, Issue 1, 2007, Pages 18-29

  Gao, Li ^a   Flores, Carlos ^b   Fan Ma, Shwu ^b   Miller, Edmund J ^c   Moitra, Jaideep ^b   Moreno, Liliana ^b   Wadgaonkar, Raj ^d   Simon, Brett ^a   Brower, Roy ^a   Sevransky, Jonathan ^a   Tuder, Rubin M ^a   Maloney, James P ^e   Moss, Marc ^e   Shanholtz, Carl ^f   Yates, C Ryan ^g   Meduri, Gianfranco Umberto ^g   Ye, Shui Q ^b   Barnes, Kathleen C ^h   Garcia, Joe G N ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MACROPHAGE MIGRATION INHIBITION FACTOR;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; CHROMOSOME 22Q; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DNA DETERMINATION; FUNCTIONAL GENOMICS; GENE LOCATION; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SEPSIS; SEPTICEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; TIDAL VOLUME;

EID: 34250656192     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2007.02.007     Document Type: Article

References (55)

1. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342 (2000) 1301-1308
2. Ware L.B., and Matthay M.A. The acute respiratory distress syndrome. N Engl J Med 342 (2000) 1334-1349
3. Slutsky A.S., and Tremblay L.N. Multiple system organ failure. Is mechanical ventilation a contributing factor?. Am J Respir Crit Care Med 157 (1998) 1721-1725
4. Kleeberger S.R., and Peden D. Gene-environment interactions in asthma and other respiratory diseases. Annu Rev Med 56 (2005) 383-400
5. Flores C., Ma S.F., Maresso K., Ahmed O., and Garcia J.G. Genomics of acute lung injury. Semin Respir Crit Care Med 27 (2006) 389-395
6. Renner P., Roger T., and Calandra T. Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clin Infect Dis 41 suppl 7 (2005) S513-S519
7. Bernhagen J., Calandra T., Mitchell R.A., Martin S.B., Tracey K.J., Voelter W., et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365 (1993) 756-759
8. Guo Y., and Xie C. [The pathogenic role of macrophage migration inhibitory factor in acute respiratory distress syndrome]. Zhonghua Jie He He Hu Xi Za Zhi 25 (2002) 337-340
9. Beishuizen A., Thijs L.G., Haanen C., and Vermes I. Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J Clin Endocrinol Metab 86 (2001) 2811-2816
10. Baugh J.A., and Bucala R. Macrophage migration inhibitory factor. Crit Care Med 30 suppl 1 (2002) S27-S35
11. Donnelly S.C., Haslett C., Reid P.T., Grant I.S., Wallace W.A., Metz C.N., et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 3 (1997) 320-323
12. Roger T., Froidevaux C., Martin C., and Calandra T. Macrophage migration inhibitory factor (MIF) regulates host responses to endotoxin through modulation of Toll-like receptor 4 (TLR4). J Endotoxin Res 9 (2003) 119-123
13. Wadgaonkar R., Dudek S.M., Zaiman A.L., Linz-McGillem L., Verin A.D., Nurmukhambetova S., et al. Intracellular interaction of myosin light chain kinase with macrophage migration inhibition factor (MIF) in endothelium. J Cell Biochem 95 (2005) 849-858
14. Garcia J.G., Davis H.W., and Patterson C.E. Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J Cell Physiol 163 (1995) 510-522
15. Dudek S.M., and Garcia J.G. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 91 (2001) 1487-1500
16. Garcia J.G., Verin A.D., Herenyiova M., and English D. Adherent neutrophils activate endothelial myosin light chain kinase: role in transendothelial migration. J Appl Physiol 84 (1998) 1817-1821
17. Petrache I., Verin A.D., Crow M.T., Birukova A., Liu F., and Garcia J.G. Differential effect of MLC kinase in TNF-alpha-induced endothelial cell apoptosis and barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 280 (2001) L1168-L1178
18. Gao L., Grant A., Halder I., Brower R., Sevransky J., Maloney J.P., et al. Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Am J Respir Cell Mol Biol 34 (2006) 487-495
19. Flores C., Ma S.F., Maresso K., Ober C., and Garcia J.G. A variant of the myosin light chain kinase gene is associated with severe asthma in African Americans. Genet Epidemiol 31 (2007) 296-305
20. Peng X., Hassoun P.M., Sammani S., McVerry B.J., Burne M.J., Rabb H., et al. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med 169 (2004) 1245-1251
21. Ye S.Q., Simon B.A., Maloney J.P., Zambelli-Weiner A., Gao L., Grant A., et al. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med 171 (2005) 361-370
22. McVerry B.J., Peng X., Hassoun P.M., Sammani S., Simon B.A., and Garcia J.G. Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. Am J Respir Crit Care Med 170 (2004) 987-993
23. Simon B.A., Easley R.B., Grigoryev D.N., Ma S.F., Ye S.Q., Lavoie T., et al. Microarray analysis of regional cellular responses to local mechanical stress in acute lung injury. Am J Physiol Lung Cell Mol Physiol 291 (2006) L851-L861
24. Bernard G.R., Artigas A., Brigham K.L., Carlet J., Falke K., Hudson L., et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149 (1994) 818-824
25. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20 (1992) 864-874
26. Knaus W.A., Draper E.A., Wagner D.P., and Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 13 (1985) 818-829
27. Donn R., Alourfi Z., De Benedetti F., Meazza C., Zeggini E., Lunt M., et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 46 (2002) 2402-2409
28. Barton A., Lamb R., Symmons D., Silman A., Thomson W., Worthington J., et al. Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun 4 (2003) 487-491
29. Nohara H., Okayama N., Inoue N., Koike Y., Fujimura K., Suehiro Y., et al. Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis. J Gastroenterol 39 (2004) 242-246
30. Donn R.P., Plant D., Jury F., Richards H.L., Worthington J., Ray D.W., et al. Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. J Invest Dermatol 123 (2004) 484-487
31. Sole X.G.E., Valls J., Iniesta R., and Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 22 (2006) 1928-1929
32. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
33. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., et al. The structure of haplotype blocks in the human genome. Science 296 (2002) 2225-2229
34. Fallin D., Cohen A., Essioux L., Chumakov I., Blumenfeld M., Cohen D., et al. Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease. Genome Res 11 (2001) 143-151
35. Palmer L.J. McCaskie PA CK. SimHap: a comprehensive modeling framework and a simulation-based approach to haplotypic analysis of population-based data (2004) Western Australian Institute for Medical Research, University of Western Australia
36. Lai K.N., Leung J.C., Metz C.N., Lai F.M., Bucala R., and Lan H.Y. Role for macrophage migration inhibitory factor in acute respiratory distress syndrome. J Pathol 199 (2003) 496-508
37. Prows D.R., McDowell S.A., Aronow B.J., and Leikauf G.D. Genetic susceptibility to nickel-induced acute lung injury. Chemosphere 51 (2003) 1139-1148
38. Armstrong L., and Millar A.B. Relative production of tumour necrosis factor alpha and interleukin 10 in adult respiratory distress syndrome. Thorax 52 (1997) 442-446
39. Calandra T., Froidevaux C., Martin C., and Roger T. Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsis. J Infect Dis 187 suppl 2 (2003) S385-S390
40. Calandra T., and Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3 (2003) 791-800
41. Grigoryev D.N., Finigan J.H., Hassoun P., and Garcia J.G. Science review: searching for gene candidates in acute lung injury. Crit Care 8 (2004) 440-447
42. Shimizu T., Nishihira J., Watanabe H., Abe R., Honda A., Ishibashi T., et al. Macrophage migration inhibitory factor is induced by thrombin and factor Xa in endothelial cells. J Biol Chem 279 (2004) 13729-13737
43. Riedemann N.C., Guo R.F., and Ward P.A. The enigma of sepsis. J Clin Invest 112 (2003) 460-467
44. Parsons P.E. Bridging the chasm between bench and bedside: translational research in acute lung injury. Am J Physiol Lung Cell Mol Physiol 286 (2004) L1086-L1087
45. Vineis P., and McMichael A.J. Bias and confounding in molecular epidemiological studies: special considerations. Carcinogenesis 19 (1998) 2063-2067
46. Browning S.R. Multilocus association mapping using variable-length Markov chains. Am J Hum Genet 78 (2006) 903-913
47. Nicolae D.L. Testing untyped alleles (TUNA)-applications to genome-wide association studies. Genet Epidemiol 30 (2006) 718-727
48. Barnes K.C., Grant A.V., Baltadzhieva D., Zhang S., Berg T., Shao L., et al. Variants in the gene encoding C3 are associated with asthma and related phenotypes among African Caribbean families. Genes Immun 7 (2006) 27-35
49. The International Hap Map Consortium. The International HapMap Project. Nature 426 (2003) 789-796
50. Baugh J.A., Chitnis S., Donnelly S.C., Monteiro J., Lin X., Plant B.J., et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 3 (2002) 170-176
51. Mitchell P., and Tollervey D. mRNA turnover. Curr Opin Cell Biol 13 (2001) 320-325
52. Mendell J.T., and Dietz H.C. When the message goes awry: disease-producing mutations that influence mRNA content and performance. Cell 16 107 (2001) 411-414
53. Jansen R.P. mRNA localization: message on the move. Nat Rev Mol Cell Biol 2 (2001) 247-256
54. Moss M., and Mannino D.M. Race and gender differences in acute respiratory distress syndrome deaths in the United States: an analysis of multiple-cause mortality data (1979-1996). Crit Care Med 30 (2002) 1679-1685
55. Martin G.S., Mannino D.M., Eaton S., and Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348 (2003) 1546-1554